{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T17:47:55Z","timestamp":1760204875050},"reference-count":9,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2016,5,14]],"date-time":"2016-05-14T00:00:00Z","timestamp":1463184000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Clin Pharm"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1007\/s11096-016-0316-3","type":"journal-article","created":{"date-parts":[[2016,5,14]],"date-time":"2016-05-14T04:35:31Z","timestamp":1463200531000},"page":"749-751","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Continuous intravenous infusion of enfuvirtide in a patient with a multidrug-resistant HIV strain"],"prefix":"10.1007","volume":"38","author":[{"given":"Robert W.","family":"Neijzen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erik M.","family":"Van Maarseveen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andy I. M.","family":"Hoepelman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annemarie M. J.","family":"Wensing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefano","family":"Bonora","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"D\u2019Avolio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tania","family":"Mudrikova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,5,14]]},"reference":[{"key":"316_CR1","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.2165\/00003495-200565080-00007","volume":"65","author":"V Oldfield","year":"2005","unstructured":"Oldfield V, Keating GM, Plosker G. Enfuvirtide: a review of its use in the management of HIV infection. Drugs. 2005;65:1139\u201360.","journal-title":"Drugs"},{"key":"316_CR2","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1056\/NEJMoa035026","volume":"348","author":"JP Lalezari","year":"2003","unstructured":"Lalezari JP, Henry K, O\u2019Hearn M, Montaner JSG, Piliero PJ, Trottier B, et al. Enfuvirtide, an HIV-1 fusion inhibitor, for drug-resistant HIV infection in North and South America. N Engl J Med. 2003;348:2175\u201385.","journal-title":"N Engl J Med"},{"key":"316_CR3","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1056\/NEJMoa035211","volume":"348","author":"A Lazzarin","year":"2003","unstructured":"Lazzarin A, Clotet B, Cooper D, Reynes J, Arasteh K, Nelson M, et al. Efficacy of enfuvirtide in patients infected with drug-resistant HIV-1 in Europe and Australia. N Engl J Med. 2003;348:2186\u201395.","journal-title":"N Engl J Med"},{"key":"316_CR4","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1067\/mcp.2002.125945","volume":"72","author":"XP Zhang","year":"2002","unstructured":"Zhang XP, Nieforth K, Lang JM, Rouzier-Panis R, Reynes J, Dorr A, et al. Pharmacokinetics of plasma enfuvirtide after subcutaneous administration to patients with human immunodeficiency virus: inverse Gaussian density absorption and 2-compartment disposition. Clin Pharmacol Ther. 2002;72:10\u20139.","journal-title":"Clin Pharmacol Ther"},{"key":"316_CR5","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.jtbi.2007.12.017","volume":"251","author":"U Mohanty","year":"2008","unstructured":"Mohanty U, Dixit NM. Mechanism-based model of the pharmacokinetics of enfuvirtide, an HIV fusion inhibitor. J Theor Biol. 2008;251:541\u201351.","journal-title":"J Theor Biol"},{"key":"316_CR6","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1097\/01.ftd.0000179421.25337.62","volume":"28","author":"A D\u2019Avolio","year":"2006","unstructured":"D\u2019Avolio A, Sciandra M, de Requena DG, Iba\u00f1ez A, Bonora S, Di Perri G. An improved HPLC fluorimetric method for the determination of T20 plasma levels in HIV-infected patients. Ther Drug Monit. 2006;28:110\u20135.","journal-title":"Ther Drug Monit"},{"key":"316_CR7","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1093\/jac\/dkr269","volume":"66","author":"S Gallien","year":"2011","unstructured":"Gallien S, Braun J, Delaugerre C, Charreau I, Reynes J, Jeanblanc F, et al. Efficacy and safety of raltegravir in treatment-experienced HIV-1-infected patients switching from enfuvirtide-based regimens: 48\u00a0week results of the randomized EASIER ANRS 138 trial. J Antimicrob Chemother. 2011;66:2099\u2013106.","journal-title":"J Antimicrob Chemother"},{"key":"316_CR8","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1093\/jac\/dkn192","volume":"62","author":"DG Requena de","year":"2008","unstructured":"de Requena DG, Bonora S, Castagna A, Hasson H, Marucco DA, D\u2019Avolio A, et al. Pharmacokinetic and pharmacodynamic determinants of early virological response to enfuvirtide-based regimens in HIV-positive patients. J Antimicrob Chemother. 2008;62:384\u20137.","journal-title":"J Antimicrob Chemother"},{"key":"316_CR9","first-page":"223","volume":"57","author":"GO Korsrud","year":"1993","unstructured":"Korsrud GO, Boison JO, Papich MG, Yates WD, MacNeil JD, Janzen ED, et al. Depletion of intramuscularly and subcutaneously injected procaine penicillin G from tissues and plasma of yearling beef steers. Can J Vet Res. 1993;57:223\u201330.","journal-title":"Can J Vet Res"}],"container-title":["International Journal of Clinical Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-016-0316-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11096-016-0316-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-016-0316-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T05:54:55Z","timestamp":1559368495000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11096-016-0316-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5,14]]},"references-count":9,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,8]]}},"alternative-id":["316"],"URL":"https:\/\/doi.org\/10.1007\/s11096-016-0316-3","relation":{},"ISSN":["2210-7703","2210-7711"],"issn-type":[{"value":"2210-7703","type":"print"},{"value":"2210-7711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,5,14]]}}}